Related Experiment Video
Updated: May 22, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Iterative experimental and virtual high-throughput screening identifies metabotropic glutamate receptor subtype 4
Ralf Mueller1, Eric S Dawson, Colleen M Niswender
1Department of Chemistry, Vanderbilt University, Nashville, TN, 37232-6600, USA.
Journal of Molecular Modeling
|May 18, 2012
Summary
Artificial neural networks identified novel modulators for metabotropic glutamate receptor subtype 4 (mGlu4), a potential Parkinson's disease treatment. This AI approach significantly enriched the discovery of active compounds from large chemical libraries.
Area of Science:
- Neuroscience
- Computational Chemistry
- Drug Discovery
Background:
- Metabotropic glutamate receptor subtype 4 (mGlu4) activation shows efficacy in Parkinson's disease models.
- High-throughput screening (HTS) identified initial modulators, but further optimization is needed.
Purpose of the Study:
- To develop and apply an artificial intelligence (AI) model for efficient discovery of novel positive allosteric modulators (PAMs) of mGlu4.
- To significantly enrich the identification of mGlu4 PAMs from large compound libraries for Parkinson's disease research.
Main Methods:
- Training artificial neural networks (ANNs) on data from a HTS campaign of ~155,000 compounds.
- Utilizing a jury system of three ANNs for compound selection and screening an external database of ~450,000 drug-like compounds.
- Experimental validation of 1,100 predicted active small molecules using two distinct mGlu4 activity assays.
Main Results:
- The ANN jury system achieved a theoretical enrichment of 15.4 when selecting the top 2% of compounds.
- Screening an external database yielded 1,100 compounds for experimental testing.
- 67 novel mGlu4 PAMs were identified, confirming activity in both assays, representing a 22-fold enrichment compared to the primary HTS (0.3% active).
Conclusions:
- AI-driven screening significantly enhances the discovery of potent mGlu4 PAMs.
- The identified compounds represent promising leads for developing new therapeutics for Parkinson's disease.
- This computational approach offers a powerful strategy for accelerating drug discovery in neuroscience.
Related Concept Videos
01:18Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...